Estimate Rate of the Women Who Have Gestational Diabetes

Diabetes, Gestational Clinical Trial

— ERD2-DIGERD  

Official title:

Retrospective Study to Estimate Screening of the Type 2 Diabetes of Women Who Had Childbirth in the Hospital Center Rene Dubos and Having Gestational Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02852980
• Other study ID #: CHRD1114
• Status: Completed
• Start date: July 2015
• Est. completion date: January 2017

Study information

• Verified date: July 2019
• Source: Centre Hospitalier René Dubos
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Retrospective study to estimate screening of the type 2 diabetes of women who had childbirth in the Hospital center Rene Dubos and having gestational diabetes.

Description:

It is recognized that pregnant women who had gestational diabetes (DG) multiplied by 7 subsequent risk of developing type 2 diabetes and this during 25 years. There is at present no formal recommendation of the High Authority for Health (HAS) as an organization of a long term screening for those women. However the recommendations of CNGOF (French Council of Gynaecologists and Obstetricians) and SFD (French society of diabetes) recommend screening for type 2 diabetes after a gestational diabetes in the postnatal consultation. But today how many women views due to a gestational diabetes have realized their screening? It is likely that the rate of occurrence of type 2 diabetes after gestational diabetes is underestimated today. Otherwise it is possible that the occurrence of type 2 diabetes is associated with some risk factors such as high BMI, insulin therapy during pregnancy. Another interrogation is the role of the doctor to reduce the number of women who do not realize their screening at 3 months postpartum. Better awareness of the importance of long term monitoring would reduce the proportion of women who do not realize their screening.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 384
• Est. completion date: January 2017
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participants aged over 18 years

• Participants who deliver between 01/01/2013 and 30/06/2015

• Participants who have had a gestational diabetes

• Participants who have been informed and have returned the questionary

Exclusion Criteria:

• Participants who do not wishing to participate in the study

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes, Gestational

Intervention

Other:
• gestational diabetes women
No intervention.

Locations

Country	Name	City	State
France	Rene Dubos Hospital	Pontoise	Val d'Oise

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier René Dubos

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glycemia realized after childbirth	The investigators want to know the number of women who realized a Glycemia analysis.	3 months
Secondary	Percentage of women who have pursued the dietary and hygiene rules	Information about dietary and hygiene rules are collected on a questionnaire.	3 months